The central nervous system (CNS), comprising the brain and spinal cord, is responsible for coordinating and influencing the development, cognition, and execution of human beings. Rapidly rising global incidence of CNS disorders has become a significant economic and social factor, yet CNS drug development remains challenging. Our scope of expertise ranges from neurodegenerative diseases to neuropsychiatric disorders, integrating behavioral, electrophysiological, analytical, histopathological and bioimaging platforms. 

At PharmaLegacy, we bring together field experts with extensive academia and industrial experience, facilitate cutting-edge technologies and provide tailored solutions fostering your preclinical CNS drug development.